Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: An observational study from the Swedish National Diabetes Register

Diabetologia

Volumn 54, Issue 10, 2011, Pages 2544-2551

  Gudbjornsdottir S ^a   Eliasson, B ^a   Eeg Olofsson, K ^a   Zethelius, B ^b   Cederholm, J ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cardiovascular disease; Diabetes mellitus; Dyslipidaemia; HbA1c; Hyperlipidaemia

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET THERAPY; DISEASE REGISTRY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 80054092573     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2218-1     Document Type: Article

References (36)

1. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 2001 Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection JAMA 285 2486 2497 10.1001/jama.285.19.2486
2. RC Turner H Millns RR Holman for the United Kingdom Prospective Diabetes Study Group, et al. 1998 Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ 316 823 828 9549452 1:STN:280:DyaK1c3htVKhsg%3D%3D (Pubitemid 28112428)
3. R D'Agostino RS Vasan MJ Pencina, et al. 2008 General cardiovascular risk profile for use in primary care. The Framingham Heart Study Circulation 117 743 753 18212285 10.1161/CIRCULATIONAHA.107.699579 (Pubitemid 351640675)
4. RJ Stevens V Kothari AI Adler IM Stratton RR Holman on behalf of the United Kingdom Prospective Diabetes Study (UKPDS) Group 2001 The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56) Clinical Science 101 671 679 11724655 10.1042/CS20000335 1:STN:280:DC%2BD3MnnvVOrtQ%3D%3D (Pubitemid 33135349)
5. RR Holman RL Coleman BSF Shine RJ Stevens 2005 Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes Diabetes Care 28 1796 1797 15983339 10.2337/diacare.28.7.1796 1:CAS:528:DC%2BD2MXms12nurk%3D (Pubitemid 40923097)
6. V Kothari RJ Stevens RR Holman for the UK Prospective Diabetes Study Group, et al. 2002 Risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study Risk Engine. UKPDS 60 Stroke 33 1776 1781 12105351 10.1161/01.STR.0000020091.07144.C7 (Pubitemid 34761059)
7. The Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 977 986 10.1056/NEJM199309303291401 (Pubitemid 23307905)
8. IM Stratton AI Adler HA Neil, et al. 2000 Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 405 412 10938048 10.1136/bmj.321.7258. 405 1:STN:280:DC%2BD3cvisFWnsg%3D%3D (Pubitemid 30609442)
9. DM Nathan PA Cleary JY Backlund, et al. 2005 Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2643 2653 16371630 10.1056/NEJMoa052187 (Pubitemid 41817713)
10. K Eeg-Olofsson J Cederholm B Eliasson, et al. 2010 Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes. An observational study from the Swedish National Diabetes Register (NDR) Diabetes Care 33 1640 1646 20424222 10.2337/dc10-0398 1:CAS:528:DC%2BC3cXpslKgs7o%3D
11. HC Gerstein J Pogue JF Mann, et al. 2005 The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE Study: a prospective epidemiological analysis Diabetologia 48 1749 1755 16059716 10.1007/s00125-005-1858-4 1:STN:280:DC%2BD2MvptF2itA%3D%3D (Pubitemid 41317828)
12. CR Elley T Kenealy E Robinson PL Drury 2008 Glycated haemoglobin and cardiovascular outcomes in people with type 2 diabetes: a large prospective cohort study Diabetes Med 25 1295 1301 1:STN:280:DC%2BD1cjnvVKiug%3D%3D
13. E Selvin S Marinopoulos G Berkenblit, et al. 2004 Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus Ann Intern Med 141 421 431 15381515 1:CAS:528:DC%2BD2cXos1Cjtrk%3D
14. A Patel S MacMahon J Chalmers the ADVANCE Collaborative Group, et al. 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2560 2572 18539916 10.1056/NEJMicm066227 1:CAS:528:DC%2BD1cXnt1yht7s%3D (Pubitemid 351214289)
15. HC Gerstein ME Miller RP Byington the Action to Control Cardiovascular Risk in Diabetes Study Group, et al. 2008 Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2545 2559 18539917 10.1056/NEJMoa0802743 1:CAS:528:DC%2BD1cXnt1Wjs7s%3D (Pubitemid 351831356)
16. W Duckworth C Abraira T Moritz, et al. 2009 Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 129 139 19092145 10.1056/NEJMoa0808431 1:CAS:528:DC%2BD1MXnsFWkug%3D%3D
17. RR Holman SK Paul A Bethel DR Matthews HAW Neil 2008 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 1577 1589 18784090 10.1056/NEJMoa0806470 1:CAS:528:DC%2BD1cXht1Wgt7nK
18. K Eeg-Olofsson J Cederholm B Eliasson, et al. 2010 New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR) J Intern Med 268 471 482 20804517 10.1111/j.1365-2796.2010.02265.x 1:STN:280: DC%2BC3cbhtFelsw%3D%3D
19. P Gaede P Vedel N Larsen G Jensen H-H Parving O Pedersen 2003 Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 383 393 12556541 10.1056/NEJMoa021778 (Pubitemid 36159355)
20. NJ Morrish SL Wang LK Stevens, et al. 2008 Mortality and causes of death in the WHO multinational study of vascular disease in diabetes Diabetologia 44 Suppl 2 S14 S21
21. S Gudbjörnsdottir J Cederholm PM Nilsson B Eliasson 2003 The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care Diabetes Care 26 1270 1276 12663609 10.2337/diacare.26.4.1270 (Pubitemid 36929284)
22. B Eliasson J Cederholm P Nilsson S Gudbjörnsdottir 2005 The gap between guidelines and reality: type 2 diabetes in a national diabetes register 1996-2003 Diabetes Med 22 1420 1426 10.1111/j.1464-5491.2005.01648.x 1:STN:280:DC%2BD2MrgsVKjtA%3D%3D (Pubitemid 41391321)
23. J Cederholm B Zethelius PM Nilsson K Eeg-Olofsson B Eliasson S Gudbjörnsdottir 2009 Effect of tight control of HbA1c and blood pressure on cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR) Diabetes Res Clin Pract 86 74 81 19679369 10.1016/j.diabres.2009.07.003 1:CAS:528:DC%2BD1MXhtFajsbfE
24. PM Nilsson J Cederholm S Gudbjörnsdottir, et al. 2009 Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register Eur J Cardiovasc Prev Rehab 16 506 512 10.1097/HJR.0b013e32832ccc50
25. K Eeg-Olofsson J Cederholm B Eliasson, et al. 2009 Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients Diabetologia 52 65 73 18985314 10.1007/s00125-008-1190-x 1:STN:280:DC%2BD1cjotVKqtA%3D%3D
26. W Hoelzel C Weykamp JO Jeppsson, et al. 2004 IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study Clin Chem 50 166 174 14709644 10.1373/clinchem.2003.024802 1:CAS:528: DC%2BD2cXovFWnsg%3D%3D (Pubitemid 38125714)
27. J Merlo U Lindblad H Pessah-Rasmussen, et al. 2000 Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers Eur J Epidemiol 16 235 243 10870938 10.1023/A:1007634722658 1:STN:280:DC%2BD3cvpsFamsg%3D%3D (Pubitemid 30351427)
28. H Tunstall-Pedoe K Kuulasmaa P Amouyel D Arveiler AM Rajakangas A Pajak 1994 Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents Circulation 90 583 612 8026046 1:STN:280:DyaK2c3pvVajtg%3D%3D
29. E Ingelsson RB D'Agostino RS Vasan, et al. 2007 Clinical utility of different lipid measures for prediction of coronary heart disease in men and women JAMA 298 776 785 17699011 10.1001/jama.298.7.776 1:CAS:528: DC%2BD2sXpt1enurg%3D (Pubitemid 47263160)
30. S Lehto T Ronnemaa K Pyörälä M Laakso 1996 Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes Stroke 27 63 68 8553405 10.1161/01.STR.27.1.63 1:STN:280:DyaK287js1antQ%3D%3D (Pubitemid 26008297)
31. KM Anderson PM Odell PWF Wilson WB Kannel 1990 Cardiovascular disease risk profiles Am Heart J 121 293 298 10.1016/0002-8703(91)90861-B
32. SG Wannamethee AG Shaper S Ebrahim 2000 HDL cholesterol, total cholesterol, and the risk of stroke in middle-aged British men Stroke 31 1882 1888 10926951 10.1161/01.STR.31.8.1882 1:CAS:528:DC%2BD3cXlvFyns7s%3D (Pubitemid 30620467)
33. JS Yudkin B Richter EA Gale 2010 Intensified glucose lowering in type 2 diabetes: time for a reappraisal Diabetologia 53 2079 2085 20686748 10.1007/s00125-010-1864-z 1:STN:280:DC%2BC3cjovV2isQ%3D%3D
34. L Czupryniak E Szymańska-Garbacz M Pawłowski M Saryusz-Wolska J Loba 2011 Intensified glucose lowering in type 2 diabetes: time for a bolder reappraisal Diabetologia 54 701 702 21161162 10.1007/s00125-010- 2011-6 1:STN:280:DC%2BC3M7ntVSisg%3D%3D
35. JH DeVries 2011 Intensified glucose lowering in type 2 diabetes: don't throw the baby out with the bathwater Diabetologia 54 705 706 21127831 10.1007/s00125-010-1991-6 1:STN:280:DC%2BC3M7mvFGkuw%3D%3D
36. JS Yudkin B Richter AM Gale 2011 Intensified glucose lowering in type 2 diabetes. Reply to Czupryniak L, Szymańska-Garbacz E, Pawłowski M et al. [letter], Aizawa T and Funase Y [letter] and DeVries JH [letter] Diabetologia 54 707 708 10.1007/s00125-010-2016-1